BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

462 related articles for article (PubMed ID: 9524432)

  • 21. Effect of nicotine and tobacco-specific nitrosamines on the metabolism of N'-nitrosonornicotine and 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone by rat oral tissue.
    Murphy SE; Heiblum R
    Carcinogenesis; 1990 Sep; 11(9):1663-6. PubMed ID: 2205411
    [TBL] [Abstract][Full Text] [Related]  

  • 22. N-nitrosamines in snuff and chewing tobacco on the Swedish market in 1983.
    Osterdahl BG; Slorach S
    Food Addit Contam; 1984; 1(4):299-305. PubMed ID: 6543619
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inhibition of herpes simplex virus replication and protein synthesis by non-smoked tobacco, tobacco alkaloids and nitrosamines.
    Larsson PA; Hirsch JM; Gronowitz JS; Vahlne A
    Arch Oral Biol; 1992 Nov; 37(11):969-78. PubMed ID: 1334651
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Decreased levels of tobacco-specific N-nitrosamines in moist snuff on the Swedish market.
    Osterdahl BG; Jansson C; Paccou A
    J Agric Food Chem; 2004 Aug; 52(16):5085-8. PubMed ID: 15291479
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Metabolites of a tobacco-specific nitrosamine, 4-(methylnitrosamino)- 1-(3-pyridyl)-1-butanone (NNK), in the urine of smokeless tobacco users: relationship between urinary biomarkers and oral leukoplakia.
    Kresty LA; Carmella SG; Borukhova A; Akerkar SA; Gopalakrishnan R; Harris RE; Stoner GD; Hecht SS
    Cancer Epidemiol Biomarkers Prev; 1996 Jul; 5(7):521-5. PubMed ID: 8827356
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Toxic and carcinogenic agents in dry and moist snuff.
    Hoffmann D; Adams JD; Lisk D; Fisenne I; Brunnemann KD
    J Natl Cancer Inst; 1987 Dec; 79(6):1281-6. PubMed ID: 3480379
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Exposure and Metabolic Activation Biomarkers of Carcinogenic Tobacco-Specific Nitrosamines.
    Hecht SS; Stepanov I; Carmella SG
    Acc Chem Res; 2016 Jan; 49(1):106-14. PubMed ID: 26678241
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Smokeless tobacco and oral cancer: a review of the risks and determinants.
    Rodu B; Jansson C
    Crit Rev Oral Biol Med; 2004 Sep; 15(5):252-63. PubMed ID: 15470264
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Chemical studies on tobacco smoke. XLII. Nitrosonornicotine: presence in tobacco, formation and carcinogenicity.
    Hoffmann D; Hecht SS; Ornaf RM; Wynder EL; Tso TC
    IARC Sci Publ (1971); 1976; (14):307-20. PubMed ID: 12092
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Tobacco-specific nitrosamines in the saliva of Inuit snuff dippers in the Northwest Territories of Canada.
    Brunnemann KD; Hornby AP; Stich HF
    Cancer Lett; 1987 Oct; 37(1):7-16. PubMed ID: 3664451
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The chemical composition of smokeless tobacco: a survey of products sold in the United States in 2006 and 2007.
    Borgerding MF; Bodnar JA; Curtin GM; Swauger JE
    Regul Toxicol Pharmacol; 2012 Dec; 64(3):367-87. PubMed ID: 23000415
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Synthesis of tobacco-specific N-nitrosamines and their metabolites and results of related bioassays.
    Amin S; Desai D; Hecht SS; Hoffmann D
    Crit Rev Toxicol; 1996; 26(2):139-47. PubMed ID: 8688157
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Tobacco-specific nitrosamines in new tobacco products.
    Stepanov I; Jensen J; Hatsukami D; Hecht SS
    Nicotine Tob Res; 2006 Apr; 8(2):309-13. PubMed ID: 16766423
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Carcinogenic substances in Soviet tobacco products.
    Zaridze DG; Safaev RD; Belitsky GA; Brunnemann KD; Hoffmann D
    IARC Sci Publ; 1991; (105):485-8. PubMed ID: 1855902
    [TBL] [Abstract][Full Text] [Related]  

  • 35. N-Nitrosomorpholine and other volatile N-nitrosamines in snuff tobacco.
    Brunnemann KD; Scott JC; Hoffmann D
    Carcinogenesis; 1982; 3(6):693-6. PubMed ID: 6889471
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Tobacco-specific nitrosamines in commercial cigarettes: possibilities for reducing exposure.
    Fischer S; Spiegelhalder B; Preussmann R
    IARC Sci Publ; 1991; (105):489-92. PubMed ID: 1855903
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparative carcinogenicity and metabolism of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone and N'-nitrosonornicotine in Syrian golden hamsters.
    Hoffmann D; Castonguay A; Rivenson A; Hecht SS
    Cancer Res; 1981 Jun; 41(6):2386-93. PubMed ID: 7237437
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Chemical and toxicological characteristics of conventional and low-TSNA moist snuff tobacco products.
    Song MA; Marian C; Brasky TM; Reisinger S; Djordjevic M; Shields PG
    Toxicol Lett; 2016 Mar; 245():68-77. PubMed ID: 26802282
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Smokeless tobacco and oral cancer: an assessment of evidence derived from laboratory animals.
    Grasso P; Mann AH
    Food Chem Toxicol; 1998 Nov; 36(11):1015-29. PubMed ID: 9771564
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Smoke yields of tobacco-specific nitrosamines in relation to FTC tar level and cigarette manufacturer: analysis of the Massachusetts Benchmark Study.
    Harris JE
    Public Health Rep; 2001; 116(4):336-43. PubMed ID: 12037262
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.